Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Immunoblastic Lymphadenopathy × Watchful Waiting × Clear all

Sponsor

Conditions

Prostatic Neoplasms 4 Squamous Intraepithelial Lesions 2 Papillomavirus Infections 2 Leukemia, Myeloid, Acute 2 HIV Infections 2 Colonic Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Anus Neoplasms 2 Solitary Fibrous Tumor, Pleural 1 Smoldering Multiple Myeloma 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Precancerous Conditions 1 Neurofibrosarcoma 1 Neuroblastoma 1 Neoplasm Metastasis 1 Mouth Neoplasms 1 Mesothelioma, Malignant 1 Melanoma 1 Malignant mesenchymal tumor 1 Lung Neoplasms 1 Liposarcoma 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Monocytic, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Erythroblastic, Acute 1 Leiomyosarcoma 1 Kidney Neoplasms 1

Interventions

fludarabine phosphate 14 Cyclophosphamide 13 Whole-Body Irradiation 11 Peripheral Blood Stem Cell Transplantation 11 Etoposide 10 Tacrolimus 9 Mycophenolic Acid 7 Rituximab 6 Methotrexate 6 Melphalan 6 Cyclosporine 6 Busulfan 6 Antilymphocyte Serum 6 Vorinostat 4 Sirolimus 4 Prednisone 4 Lenalidomide 4 Immunohistochemistry 4 Gene Expression Profiling 4 Carboplatin 4 Vincristine 3 Microarray Analysis 3 Everolimus 3 Doxorubicin 3 Dexamethasone 3 Alemtuzumab 3 thymoglobulin 2 prednylidene 2 fludarabine 2 etoposide phosphate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡